Clinical Trial Update: A Long-Term Safety and Effectiveness Study to Evaluate Pitolisant in Adult Patients With Idiopathic Hypersomnia [Phase 3]

View source ↗

Summary

A completed Phase 3 long-term study assessing the safety and effectiveness of pitolisant in adult patients with idiopathic hypersomnia, including excessive dayt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness
• Idiopathic Hypersomnia

Drugs mentioned

• WAKIX (pitolisant hydrochloride)

Snippet

Sponsor: Harmony Biosciences Management, Inc. | Conditions: Idiopathic Hypersomnia, Excessive Daytime Sleepiness | Phase 3 | Status: COMPLETED